VERSA™, manufactured by the company Revanesse®, is a hyaluronic acid (HA) dermal filler developed to smooth fine lines and wrinkles and enhance facial volume. VERSA received its FDA approval for use in the United States in 2017. VERSA is comparable to other HA fillers like Restylane® and Juvederm®, there are some characteristics that make it unique and may influence your decision to try one over the other. The key factor that seems to make VERSA™ different than other HA fillers, is its nearly non-existent post-injection swelling. VERSA™ has been shown to produce 24% less swelling than competing fillers.
On a molecular level, VERSA™ has a tiny, spherical particle structure which gives it a very smooth quality that yields very natural-looking results. VERSA™ is manufactured with premium quality hyaluronic acid and has a higher molecular weight than other HA fillers which may result in longer-lasting results.
VERSA™ results are seen immediate after treatment. VERSA™ is a long-lasting soft tissue filler. The benefits of one treatment can last up to 6-12 months.
